Literature DB >> 15525660

Recessive mutations in PTHR1 cause contrasting skeletal dysplasias in Eiken and Blomstrand syndromes.

Sabine Duchatelet1, Elsebet Ostergaard, Dina Cortes, Arnaud Lemainque, Cécile Julier.   

Abstract

Eiken syndrome is a rare autosomal recessive skeletal dysplasia. We identified a truncation mutation in the C-terminal cytoplasmic tail of the parathyroid hormone (PTH)/PTH-related peptide (PTHrP) type 1 receptor (PTHR1) gene as the cause of this syndrome. Eiken syndrome differs from Jansen and Blomstrand chondrodysplasia and from enchondromatosis, which are all syndromes caused by PTHR1 mutations. Notably, the skeletal features are opposite to those in Blomstrand chondrodysplasia, which is caused by inactivating recessive mutations in PTHR1. To our knowledge, this is the first description of opposite manifestations resulting from distinct recessive mutations in the same gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15525660     DOI: 10.1093/hmg/ddi001

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  22 in total

Review 1.  Non-canonical signaling of the PTH receptor.

Authors:  Jean-Pierre Vilardaga; Thomas J Gardella; Vanessa L Wehbi; Timothy N Feinstein
Journal:  Trends Pharmacol Sci       Date:  2012-06-16       Impact factor: 14.819

Review 2.  Molecular basis of parathyroid hormone receptor signaling and trafficking: a family B GPCR paradigm.

Authors:  Jean-Pierre Vilardaga; Guillermo Romero; Peter A Friedman; Thomas J Gardella
Journal:  Cell Mol Life Sci       Date:  2010-08-12       Impact factor: 9.261

Review 3.  International Union of Basic and Clinical Pharmacology. XCIII. The parathyroid hormone receptors--family B G protein-coupled receptors.

Authors:  Thomas J Gardella; Jean-Pierre Vilardaga
Journal:  Pharmacol Rev       Date:  2015       Impact factor: 25.468

Review 4.  Wolcott-Rallison syndrome.

Authors:  Cécile Julier; Marc Nicolino
Journal:  Orphanet J Rare Dis       Date:  2010-11-04       Impact factor: 4.123

5.  Duplication of PTHLH causes osteochondroplasia with a combined brachydactyly type E/A1 phenotype with disturbed bone maturation and rhizomelia.

Authors:  Ricarda Flöttmann; Anna Sowinska-Seidler; Julie Lavie; Jean-François Chateil; Didier Lacombe; Stefan Mundlos; Denise Horn; Malte Spielmann
Journal:  Eur J Hum Genet       Date:  2016-01-06       Impact factor: 4.246

6.  Expanding the spectrum of PTH1R mutations in patients with primary failure of tooth eruption.

Authors:  Helmut Roth; Lars G Fritsche; Christoph Meier; Peter Pilz; Martin Eigenthaler; Philipp Meyer-Marcotty; Angelika Stellzig-Eisenhauer; Peter Proff; Cláudia M Kanno; Bernhard Hf Weber
Journal:  Clin Oral Investig       Date:  2013-06-15       Impact factor: 3.573

Review 7.  PTH receptor-1 signalling-mechanistic insights and therapeutic prospects.

Authors:  Ross W Cheloha; Samuel H Gellman; Jean-Pierre Vilardaga; Thomas J Gardella
Journal:  Nat Rev Endocrinol       Date:  2015-08-25       Impact factor: 43.330

8.  PTHR1 loss-of-function mutations in familial, nonsyndromic primary failure of tooth eruption.

Authors:  Eva Decker; Angelika Stellzig-Eisenhauer; Britta S Fiebig; Christiane Rau; Wolfram Kress; Kathrin Saar; Franz Rüschendorf; Norbert Hubner; Tiemo Grimm; Bernhard H F Weber
Journal:  Am J Hum Genet       Date:  2008-12       Impact factor: 11.025

9.  Novel mutations in PTH1R associated with primary failure of eruption and osteoarthritis.

Authors:  S A Frazier-Bowers; H M Hendricks; J T Wright; J Lee; K Long; C F Dibble; S Bencharit
Journal:  J Dent Res       Date:  2013-12-03       Impact factor: 6.116

Review 10.  Signaling Pathways in Bone Development and Their Related Skeletal Dysplasia.

Authors:  Alessandra Guasto; Valérie Cormier-Daire
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.